'T-cell prolymphocytic leukemia (T-PLL), a heterogeneous disease exemplified by two cases and the important role of cytogenetics: a multidisciplinary approach'
A novel three-way rearrangement involving ETV6 (12p13) and ABL1 (9q34) with an unknown partner on 3p25 resulting in a possible ETV6-ABL1 fusion in a patient with acute myeloid leukemia: a case report and a review of the literature.
Autorzy:
TiradoCA; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 USA ; Department of Pathology and Laboratory Medicine, UCLA, West Medical Building, 1010 Veteran Ave, Second Floor room 2212F, Los Angeles, CA 90024 USA. Siangchin K; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 USA. Shabsovich DS; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 USA. Sharifian M; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 USA. Schiller G; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 USA.
Pokaż więcej
Źródło:
Biomarker research [Biomark Res] 2016 Aug 25; Vol. 4 (1), pp. 16. Date of Electronic Publication: 2016 Aug 25 (Print Publication: 2016).
Erratum to: A case of B-cell acute lymphoblastic leukemia in a child with Down syndrome bearing a t(2;12)(p12;p13) involving ETV6 and biallelic IGH@ rearrangements.
Autorzy:
TiradoCA; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA USA. Shabsovich D; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA USA. Kim Y; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA USA. Traum P; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA USA. Pullarkat S; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA USA. Kallen M; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA USA. Rao N; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA USA.
Pokaż więcej
Źródło:
Biomarker research [Biomark Res] 2015 Nov 02; Vol. 3, pp. 27. Date of Electronic Publication: 2015 Nov 02 (Print Publication: 2015).
A case of B-cell acute lymphoblastic leukemia in a child with Down syndrome bearing a t(2;12)(p12;p13) involving ETV6 and biallelic IGH@ rearrangements.
Autorzy:
TiradoCA; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA USA. Shabsovich D; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA USA. Kim Y; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA USA. Traum P; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA USA. Pullarkat S; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA USA. Kallen M; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA USA. Rao N; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA USA.
Pokaż więcej
Źródło:
Biomarker research [Biomark Res] 2015 Jun 05; Vol. 3, pp. 11. Date of Electronic Publication: 2015 Jun 05 (Print Publication: 2015).
A (1;19) translocation involving TCF3-PBX1 fusion within the context of a hyperdiploid karyotype in adult B-ALL: a case report and review of the literature.
Autorzy:
TiradoCA; Department of Pathology and Laboratory Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA 90024 USA. Shabsovich D; Department of Pathology and Laboratory Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA 90024 USA. Yeh L; Department of Pathology and Laboratory Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA 90024 USA. Pullarkat ST; Department of Pathology and Laboratory Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA 90024 USA. Yang L; Department of Pathology and Laboratory Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA 90024 USA. Kallen M; Department of Pathology and Laboratory Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA 90024 USA. Rao N; Department of Pathology and Laboratory Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA 90024 USA.
Pokaż więcej
Źródło:
Biomarker research [Biomark Res] 2015 Feb 18; Vol. 3, pp. 4. Date of Electronic Publication: 2015 Feb 18 (Print Publication: 2015).
James AW; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. Chang L; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. Shrestha S; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. TiradoCA; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. Dry SM; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Pokaż więcej
Źródło:
Journal of orthopaedics [J Orthop] 2015 Jan 29; Vol. 12 (1), pp. 58-62. Date of Electronic Publication: 2015 Jan 29 (Print Publication: 2015).
Childhood B-acute lymphoblastic leukemia: a genetic update.
Autorzy:
Woo JS; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, 1010 Veteran Ave, 2nd Floor, room 2212 F, Los Angeles, CA 90024, USA. Alberti MO; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, 1010 Veteran Ave, 2nd Floor, room 2212 F, Los Angeles, CA 90024, USA. TiradoCA; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, 1010 Veteran Ave, 2nd Floor, room 2212 F, Los Angeles, CA 90024, USA.
Pokaż więcej
Źródło:
Experimental hematology & oncology [Exp Hematol Oncol] 2014 Jun 13; Vol. 3, pp. 16. Date of Electronic Publication: 2014 Jun 13 (Print Publication: 2014).
Acute myeloid leukemia with t(7;21)(p22;q22) and 5q deletion: a case report and literature review.
Autorzy:
Ji J; Cytogenetics, Department of Pathology & Laboratory Medicine, David Geffen School of Medicine at UCLA, UCLA, Los Angeles, CA, USA. Loo E; Hematopathology, Department of Pathology & Laboratory Medicine, David Geffen School of Medicine at UCLA, UCLA, Los Angeles, CA, USA. Pullarkat S; Hematopathology, Department of Pathology & Laboratory Medicine, David Geffen School of Medicine at UCLA, UCLA, Los Angeles, CA, USA. Yang L; Cytogenetics, Department of Pathology & Laboratory Medicine, David Geffen School of Medicine at UCLA, UCLA, Los Angeles, CA, USA. TiradoCA; Cytogenetics, Department of Pathology & Laboratory Medicine, David Geffen School of Medicine at UCLA, UCLA, Los Angeles, CA, USA.
Pokaż więcej
Źródło:
Experimental hematology & oncology [Exp Hematol Oncol] 2014 Mar 19; Vol. 3, pp. 8. Date of Electronic Publication: 2014 Mar 19 (Print Publication: 2014).
Abnormal karyotypes in osteochondroma: Case series and literature review.
Autorzy:
James AW; Department of Pathology & Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. TiradoCA; Department of Pathology & Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. Levine B; Department of Radiology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. Dry SM; Department of Pathology & Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Pokaż więcej
Źródło:
Journal of orthopaedics [J Orthop] 2014 Jan 30; Vol. 12 (2), pp. 70-4. Date of Electronic Publication: 2014 Jan 30 (Print Publication: 2015).
A case of pediatric B-Lymphoblastic leukemia presenting with a t(9;12)(p24;q11.2) involving JAK2 and concomitant MLL rearrangement with apparent insertion at 6q27.
Autorzy:
TiradoCA; Department of Pathology and Laboratory Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA 90095, USA. Shabsovich D; Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA 90095, USA. DeNicola M; Department of Pathology and Laboratory Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA 90095, USA. Rao D; Department of Pathology and Laboratory Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA 90095, USA. Yang L; Department of Pathology and Laboratory Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA 90095, USA. Garcia R; UT Southwestern Medical Center Department of Pathology, Dallas, Texas, USA. Rao N; Department of Pathology and Laboratory Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA 90095, USA.
Pokaż więcej
Źródło:
Biomarker research [Biomark Res] 2013 Nov 25; Vol. 1 (1), pp. 31. Date of Electronic Publication: 2013 Nov 25.
Atypical rearrangement involving 3'-IGH@ and a breakpoint at least 400 Kb upstream of an intact MYC in a CLL patient with an apparently balanced t(8;14)(q24.1;q32) and negative MYC expression.
Autorzy:
Amarillo I; Clinical Molecular Cytogenetics Laboratory, Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA, USA.; Department of Pathology & Laboratory, Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA, USA. Bui PH; Clinical Molecular Cytogenetics Laboratory, Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA, USA.; Department of Pathology & Laboratory, Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA, USA. Kantarci S; Clinical Molecular Cytogenetics Laboratory, Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA, USA.; Department of Pathology & Laboratory, Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA, USA. Rao N; Clinical Molecular Cytogenetics Laboratory, Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA, USA.; Department of Pathology & Laboratory, Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA, USA. Shackley BS; Department of Pathology & Laboratory, Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA, USA. García R; Cytogenetics, UT Southwestern Medical Center, Dallas, TX, USA. TiradoCA; Clinical Molecular Cytogenetics Laboratory, Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA, USA.; Department of Pathology & Laboratory, Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA, USA.
Pokaż więcej
Źródło:
Molecular cytogenetics [Mol Cytogenet] 2013 Feb 01; Vol. 6 (1), pp. 5. Date of Electronic Publication: 2013 Feb 01.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies